Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, October 2, 2019
[ Wed, Oct 02nd 2019
] - WOPRAI
[ Wed, Oct 02nd 2019
] - WOPRAI
[ Wed, Oct 02nd 2019
] - WOPRAI
[ Wed, Oct 02nd 2019
] - WOPRAI
[ Wed, Oct 02nd 2019
] - WOPRAI
[ Wed, Oct 02nd 2019
] - WOPRAI
[ Wed, Oct 02nd 2019
] - WOPRAI
[ Wed, Oct 02nd 2019
] - WOPRAI
[ Wed, Oct 02nd 2019
] - WOPRAI
[ Wed, Oct 02nd 2019
] - WOPRAI
[ Wed, Oct 02nd 2019
] - WOPRAI
[ Wed, Oct 02nd 2019
] - WOPRAI
[ Wed, Oct 02nd 2019
] - WOPRAI
[ Wed, Oct 02nd 2019
] - WOPRAI
[ Wed, Oct 02nd 2019
] - WOPRAI
[ Wed, Oct 02nd 2019
] - WOPRAI
[ Wed, Oct 02nd 2019
] - WOPRAI
Tue, October 1, 2019
[ Tue, Oct 01st 2019
] - WOPRAI
[ Tue, Oct 01st 2019
] - WOPRAI
[ Tue, Oct 01st 2019
] - WOPRAI
[ Tue, Oct 01st 2019
] - WOPRAI
[ Tue, Oct 01st 2019
] - WOPRAI
[ Tue, Oct 01st 2019
] - WOPRAI
Benjamin Burnett Initiated (BLUE) at Hold and Held Target at $109 on, Oct 1st, 2019
Benjamin Burnett of Stifel, Initiated "bluebird bio, Inc." (BLUE) at Hold and Held Target at $109 on, Oct 1st, 2019.
Benjamin has made no other calls on BLUE in the last 4 months.
There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 1 agrees with Benjamin's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $136 on, Tuesday, August 6th, 2019
These are the ratings of the 2 analyists that currently disagree with Benjamin
- Jason McCarthy of "Maxim Group" Upgraded from Hold to Strong Buy and Held Target at $160 on, Tuesday, June 18th, 2019
- Matthew Luchini of "BMO Capital" Maintained at Buy with Decreased Target to $163 on, Monday, June 17th, 2019
